questionsmedicales.fr
Cellules
Neurones
Neurofibres myélinisées
Neurofibres myélinisées : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Neuropathie
Électromyographie
Imagerie par résonance magnétique
Myéline
Symptômes neurologiques
Douleur
Tests génétiques
Neuropathies héréditaires
Antécédents médicaux
Facteurs de risque
Symptômes
5
Neuropathie
Symptômes neurologiques
Évolution des symptômes
Neuropathie
Prévention
5
Prévention
Maladies chroniques
Prévention des blessures
Traumatismes
Traitements
5
Traitement
Physiothérapie
Analgésiques
Anticonvulsivants
Physiothérapie
Réhabilitation
Médecine alternative
Acupuncture
Médecine personnalisée
Traitement
Complications
5
Complications
Douleurs chroniques
Gestion des complications
Équipe multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Diabète
Hérédité
Neuropathies héréditaires
Vieillissement
Neuropathie
Maladies auto-immunes
Sclérose en plaques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres myélinisées : Questions médicales les plus fréquentes",
"headline": "Neurofibres myélinisées : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres myélinisées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées",
"alternateName": "Nerve Fibers, Myelinated",
"code": {
"@type": "MedicalCode",
"code": "D009413",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yang Shen",
"url": "https://questionsmedicales.fr/author/Yang%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Xingtao Zhou",
"url": "https://questionsmedicales.fr/author/Xingtao%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Markus Axer",
"url": "https://questionsmedicales.fr/author/Markus%20Axer",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Genetic Revolution: Cancer Genetic Testing and Counseling.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37195154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Prenatal genetic testing 1: screening tests.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36081381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001172"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prenatal genetic testing 2: diagnostic tests.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36081360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001174"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elective genetic testing: Genetics professionals' perspectives and practices.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36575824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jgc4.1666"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic Testing in Parkinson's Disease.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37365908",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29500"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres myélinisées",
"item": "https://questionsmedicales.fr/mesh/D009413"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres myélinisées - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres myélinisées",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres myélinisées",
"description": "Comment diagnostiquer une neuropathie myélinisée ?\nQuels tests d'imagerie sont utilisés ?\nQuels signes cliniques indiquent une atteinte myélinisée ?\nPeut-on détecter des anomalies génétiques ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres myélinisées",
"description": "Quels sont les symptômes courants des neuropathies myélinisées ?\nLes symptômes varient-ils selon l'âge ?\nComment les symptômes évoluent-ils ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres myélinisées",
"description": "Peut-on prévenir les neuropathies myélinisées ?\nQuel rôle joue le mode de vie dans la prévention ?\nLes vaccinations peuvent-elles aider ?\nComment éviter les blessures nerveuses ?\nLe stress a-t-il un impact sur la santé nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres myélinisées",
"description": "Quels traitements sont disponibles pour les neuropathies myélinisées ?\nLes médicaments peuvent-ils soulager la douleur ?\nLa physiothérapie est-elle bénéfique ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres myélinisées",
"description": "Quelles complications peuvent survenir ?\nLes neuropathies peuvent-elles entraîner des handicaps ?\nY a-t-il un risque accru de chutes ?\nLes complications peuvent-elles affecter la santé mentale ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres myélinisées",
"description": "Quels sont les principaux facteurs de risque ?\nL'hérédité joue-t-elle un rôle ?\nLe vieillissement est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Genetic+Testing#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie myélinisée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un électromyogramme (EMG) et des études de conduction nerveuse sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut aider à visualiser les lésions nerveuses et la myéline."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte myélinisée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des engourdissements, des faiblesses ou des douleurs peuvent indiquer cela."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations liées à des neuropathies."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des maladies sous-jacentes ou des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des neuropathies myélinisées ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Engourdissements, picotements, douleurs, faiblesse musculaire et réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver progressivement ou apparaître par poussées selon la cause."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses ou une perte de fonction soudaine nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent limiter les activités quotidiennes et affecter le bien-être général."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies myélinisées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines neuropathies peuvent être évitées en contrôlant les maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est crucial."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations préviennent des infections pouvant causer des neuropathies."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures nerveuses ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les positions prolongées et les traumatismes peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé nerveuse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les symptômes nerveux et affecter la santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les neuropathies myélinisées ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la médication, la physiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle bénéfique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme l'acupuncture peuvent être envisagées, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés selon la cause et la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la perte de fonction, des douleurs chroniques et des infections."
}
},
{
"@type": "Question",
"name": "Les neuropathies peuvent-elles entraîner des handicaps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des neuropathies sévères peuvent entraîner des handicaps fonctionnels significatifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de chutes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la faiblesse musculaire et les troubles de l'équilibre augmentent le risque de chutes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et la perte de fonction peuvent mener à l'anxiété et à la dépression."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins, physiothérapeutes et psychologues est essentielle."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines neuropathies sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement augmente le risque de développer des neuropathies myélinisées."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques augmentent le risque de neuropathies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, EYE & ENT Hospital of Fudan University, 19 Baoqing Road, Shanghai, 200031, China.
NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China (Q.Z.).
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Physics, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.
Publications dans "Neurofibres myélinisées" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany.
Publications dans "Neurofibres myélinisées" :
Genetic counseling is a relatively young profession that has advanced rapidly over the last 50 years. The term "genetic counseling" was first coined by Sheldon Reed in 1947 to describe the advice he w...
Prenatal genetic testing can be divided into two categories: screening and diagnostic. This article will focus on reviewing prenatal genetic screening tests....
Cell-free DNA (cfDNA) is a new prenatal genetic screening test with a high degree of accuracy for identifying certain genetic conditions like trisomy 21, 18, and 13. However, cfDNA has also been appli...
Prenatal genetic screening evaluates at risk pregnancies - including both carrier screening, which can be done at any point in a person's life, and aneuploidy screening, which is done during pregnancy...
Prenatal genetic testing can be divided into two categories: screening and diagnosis. Prenatal genetic screening tests are used to assess carrier status or as a fetal risk assessment for a particular ...
Next generation sequencing (NGS) has revolutionized prenatal genetic diagnostic testing. NGS methods are becoming more advanced and accurate as more genetic information is being linked to genetic cond...
Prenatal genetic diagnostic testing involves clinicians invasively obtaining tissue via amniocentesis or chorionic villus sampling to identify if a fetus has a genetic condition. This testing has trad...
Elective genetic testing (EGT) to identify disease risk in individuals who may or may not meet clinical criteria for testing is increasingly being offered in clinical practice. However, little is know...
Genetic testing for persons with Parkinson's disease is becoming increasingly common. Significant gains have been made regarding genetic testing methods, and testing is becoming more readily available...
There are thousands of different clinical genetic tests currently available. Genetic testing and its applications continue to change rapidly for multiple reasons. These reasons include technological a...
This article considers a number of key issues and axes related to the current and future state of clinical genetic testing, including targeted versus broad testing, simple/Mendelian versus polygenic a...
Genetic testing is expanding and evolving, including into new clinical applications. Developments in the field of genetics will likely result in genetic testing becoming increasingly in the purview of...
Implementation of genetic testing in healthcare increases, but access to, and number of, genetics providers remain scarce. This study analyzed the impact of genetic counselor (GC) involvement on frequ...
To evaluate the feasibility and impact of offering genetic testing and counseling to patients with Parkinson's disease (PD), with the potential to enroll in gene-targeted clinical trials and improve c...
A multicenter, exploratory pilot study at 7 academic hospital sites in the United States tracked enrollment and randomized participants to receive results and genetic counseling at local sites or by g...
From September 5, 2019 to January 4, 2021, 620 participants were enrolled and 387 completed outcome surveys. There were no significant differences in outcomes between local and remote sites, with both...
Local clinicians, as well as genetic counselors, with educational support as needed, can effectively return genetic results for PD as we observed favorable outcome measures in both groups. Increasing ...
Clinical guidelines recommend genetic testing when evaluating congenital and late-onset sensorineural hearing loss (SNHL). Genetic diagnoses can provide parents additional information regarding antici...
We included children ages 0-18 years with SNHL who were hearing aid or cochlear implant candidates but non-users and underwent hearing-loss gene panel testing prior to initiating intervention. Univari...
Of the 385 children with SNHL who underwent hearing loss gene panel testing, 111 were included. Median age was 7.5 years. 56% were underrepresented minorities, 71% were non-White, and 71% were publicl...
Up to half of children with SNHL are suspected to have an underlying genetic etiology. Children diagnosed with a genetic diagnosis are significantly more likely to subsequently utilize hearing aids or...
4 Laryngoscope, 133:1982-1986, 2023....
Leukodystrophies are monogenic disorders primarily affecting the white matter. We aimed to evaluate the utility of genetic testing and time-to-diagnosis in a retrospective cohort of children with susp...
Medical records of patients who attended the leukodystrophy clinic at the Dana-Dwek Children's Hospital between June 2019 and December 2021 were retrieved. Clinical, molecular, and neuroimaging data w...
Sixty-seven patients (Female/Male ratio 35/32) were included. Median age at symptom onset was 9 months (interquartile range (IQR) 3-18 months), and median length of follow-up was 4.75 years (IQR 3-8.5...
NGS carries the highest diagnostic yield in children with suspected leukodystrophy. Access to advanced sequencing technologies accelerates speed to diagnosis, which is increasingly crucial as targeted...